97.99
[1]. Amit Bhoil, et al. Can 3'-deoxy-3'-(18)F-fluorothymidine or 2'-deoxy-2'-(18)F-fluoro-d-glucose PET/CT better assess response after 3-weeks treatment by epidermal growth factor receptor kinase inhibitor, in non-small lung cancer patients? Preliminary results. Hell J Nucl Med. 201 May-Aug;17(2):90-6.
[2]. Benjamin Bondue, et al. PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis. J Nucl Med. 201 Jan;6(1):127-32.
[3]. Chi-lai Ho, et al. 11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT. J Nucl Med. 201 May;():79-2.
[]. Hayato Kaida, et al. Hypermetabolic pulmonary and bone marrow lesions in a patient with chronic adult T-cell leukemia. Hell J Nucl Med. 201 May-Aug;17(2):1-7.
[]. Natalie Spaccarelli, et al. Role of (18)F-fluorodeoxyglucose positron emission tomography imaging in the management of primary cutaneous lymphomas. Hell J Nucl Med. 201 May-Aug;17(2):78-8.
H31-H319-H33
P261-P26-P271-P280-P302+P32-P30+P30-P362+P36-P0-P01